Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Liver Neoplasms × Metformin × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 21 Insulin Resistance 5 Obesity 4 Neoplasms 3 Prostatic Neoplasms 2 Motor Activity 2 Menstruation Disturbances 2 Medulloblastoma 2 Infertility 2 Diabetes Mellitus 2 Breast Neoplasms 2 Weight Loss 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Toxemia 1 Thyroid Neoplasms 1 Premature Birth 1 Pregnancy Complications 1 Prediabetic State 1 Pre-Eclampsia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-DM Stage II High-risk Colorectal Cancer 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Metabolic Syndrome 1 Liver Neoplasms 1 Infertility, Female 1 Hyperinsulinism 1 Hyperandrogenism 1

Interventions

Sorafenib 8 durvalumab 4 Cisplatin 4 Gemcitabine 3 Ethiodized Oil 3 Doxorubicin 3 Chemotherapy, Adjuvant 3 Bevacizumab 3 tremelimumab 2 sodium thiosulfate 2 phosphomannopentaose sulfate 2 Watchful Waiting 2 Talaporfin 2 Radiofrequency Ablation 2 Oxaliplatin 2 Nivolumab 2 Folfox protocol 2 Celecoxib 2 Capecitabine 2 Analgesia, Patient-Controlled 2 seocalcitol 1 parecoxib 1 nolatrexed 1 linifanib 1 lenvatinib 1 ferumoxides 1 ferric carboxymaltose 1 contrast agent BR1 1 cabozantinib 1 brivanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03184493 2019-05-31

XBD

Guangxi Medical University

Phase 3 Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡